Showing results (81-90 of 133) with videos related to
Sort By:
Pageof 14
Immunobiology|April 25, 2000
Lipopeptides as immunoadjuvants and immunostimulants in mucosal immunizationW Baier, N Masihi, M Huber, et al.Versicherungsmedizin|June 1, 1990
[Echocardiographic functional parameters of the left ventricle as a prognostic indicator in coronary heart disease]G D Kneissl, N Reifart, U Fritz, et al.Forensic Science International|December 6, 2020
Accurate prediction of saw blade thicknesses from false start measurementsK Alsop, W Baier, D Norman, et al.Acta Anatomica|January 1, 1991
Monoclonal antibodies against a human juxtaglomerular epithelioid granular cell tumourR Andreessen, W Baier, P Corvol, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|February 9, 1996
A simple method for screening for Farber disease on cultured skin fibroblastsM Chatelut, J Feunteun, K Harzer, et al.Journal of Neurology|October 1, 1987
Adrenoleukodystrophy in an adult female. A clinical, morphological, and neurochemical studyW Schlote, B Molzer, J Peiffer, et al.FEBS Letters|December 31, 1997
Saposins (sap) A and C activate the degradation of galactosylceramide in living cellsK Harzer, B C Paton, H Christomanou, et al.Casopis Lekaru Ceskych|March 23, 1990
[Fabry's disease with isolated disease of the cardiac muscle, manifesting as hypertrophic cardiomyopathy]M Elleder, V Dorazilová, V Bradová, et al.American Journal of Hematology|September 2, 1998
Coincidence of Gaucher's disease due to a private mutation and Ph' positive chronic myeloid leukemiaP E Petrides, P leCoutre, J Müller-Höcker, et al.European Journal of Pediatrics|October 1, 1989
Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidosesK Harzer, B C Paton, A Poulos, et al.Pageof 14